Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Finding financial help fast can be essential during emergencies. Explore various resources to access the support you need quickly.
22,851 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
SpaceX remains privately held, but chatter about a public listing fuels the myth that a superstar IPO will power the ...
Apple hikes prices on Macs and iPads amid a sharp rise in memory chip costs driven by AI infrastructure demand. The m...
When a Tanger director cashed $518,000, investors take notice. This article breaks down insider trades, what signals ...
As AI spending surges, a handful of ETFs offer broad, diversified access to the AI boom. Four funds map to the AI sta...
Accenture warns AI’s carbon footprint could rise 11-fold by 2030 as data centers multiply worldwide. The piece examin...
Analysts outline a path for Amazon to approach $300 in the next 12-15 months, anchored by cloud, ads, and Prime-drive...
Income investors are weighing two popular S&P 500 covered-call ETFs. This piece breaks down how SPYI and JEPI generat...
Tenable’s stock jumped on Monday, marking a sharp continuation of a rally that started in the spring. This article di...
Unilever is betting big on the 2026 World Cup, weaving social, digital and in-store campaigns to turn fans into loyal...
Tech giants swing on headlines. This guide unpacks why meta stock dropped then, how the rebound happened, and what in...
The OCC has approved Circle National Trust to operate as a national fiduciary bank focused on custody services, not r...